Related Experiment Video

Updated: Jun 17, 2026

High-Throughput Dissociation and Orthotopic Implantation of Breast Cancer Patient-Derived Xenografts
06:06

High-Throughput Dissociation and Orthotopic Implantation of Breast Cancer Patient-Derived Xenografts

Published on: December 20, 2024

Building a statewide clinical trials network for cancer care in West Virginia

Jame Abraham1, James Keresztury, John Azar

  • 1Mary Babb Randolph Cancer Center, West Virginia University School of Medicine, Morgantown, WV, USA.

The West Virginia Medical Journal
|December 17, 2009
PubMed

Insights

Clinical trial participation for adult cancer patients in the US is low, especially in rural areas. A new statewide network aims to improve access to cancer clinical trials and advance cancer care.

Area of Science:

  • Oncology
  • Clinical Research
  • Public Health

Background:

  • Cancer mortality rates are declining for some tumors, but advanced stages often remain incurable.
  • Cancer treatment is continually evolving, with clinical trials offering pathways to new therapies.
  • Less than 3% of adult cancer patients in the US participate in clinical trials.

Purpose of the Study:

  • To address challenges in cancer care and clinical trial access in rural states like West Virginia.
  • To develop a statewide cancer clinical trials network to improve patient outcomes.
  • To create a potential model for other states and diseases.

Main Methods:

  • Recognizing barriers to clinical trial awareness and access.
  • Initiating the formative stages of developing a statewide network.
  • Engaging oncology leaders within the state.

Main Results:

  • Currently in formative stages, the network's full impact is yet to be realized.
  • The initiative aims to overcome geographical and population dispersion challenges.
  • Anticipates significant positive impact on state-level cancer care.

Conclusions:

  • A statewide cancer clinical trials network is being developed in West Virginia.
  • This initiative seeks to enhance access to novel cancer treatments.
  • The network may serve as a replicable model for other regions and diseases.

More Related Videos

Modeling Chemotherapy Resistant Leukemia In Vitro08:41

Modeling Chemotherapy Resistant Leukemia In Vitro

Published on: February 9, 2016

Multi-photon Imaging of Tumor Cell Invasion in an Orthotopic Mouse Model of Oral Squamous Cell Carcinoma12:03

Multi-photon Imaging of Tumor Cell Invasion in an Orthotopic Mouse Model of Oral Squamous Cell Carcinoma

Published on: July 25, 2011

Related Concept Videos

Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...